Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on Document Capture Technologies, Inc.


NEW YORK, NY--(Marketwire - April 6, 2011) - Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview® (EIO®) on Document Capture Technologies, Inc. (OTCBB: DCMT). The full 48-page report can be found at www.crystalra.com.

Over the past decade, information management has become increasingly important worldwide, particularly with regard to how information is stored and shared. Accordingly, Document Capture Technologies, Inc. ("DCT" or "the Company") develops document and image capture products that transform business-critical papers into a manageable digital format.

DCT has worked for the past several years to provide cost-effective and accurate mobile scanners as alternatives to manual data entry. The Company's flexible and mobile scanning solutions create usable electronic content suited for database, document, content, and other systems. In doing so, these solutions are intended to reduce organizations' operating costs, improve information accuracy, and speed-up processing time. DCT seeks to provide a seamless operational link between the scanner and data-collecting device by providing a customized interface based upon specific client needs. The Company believes it creates a competitive barrier that separates it from a commodity-type business.

To DCT's knowledge, it ranks among the world's largest developers of USB-powered, page-fed document capture platforms today. Since its first scanner was introduced in 2002, DCT has shipped an estimated four million products for both business and personal use.

Be the first to hear about Crystal Research's new report releases and upcoming media coverage. Follow us on Twitter at http://twitter.com/crystalresearch or visit http://crystalra.com/blog/ to stay up-to-date on industry and company news for clients under our research coverage.

About Crystal Research Associates, LLC

Crystal Research Associates, LLC is an independent research firm that provides institutional-quality research on small- and mid-cap companies. The firm is led by veteran Wall Street sell-side analyst Jeffrey Kraws, who is well known by the international financial media for his years of work on Wall Street and for providing consistent award-winning analyses and developing long-term relationships on both the buy-side and sell-side. He has been consistently ranked on Wall Street among the Top Ten Analysts for pharmaceutical stock performance in the world for almost two decades as well as ranked as the Number One Stock Picker in the world for pharmaceuticals by Starmine and for estimates from Zacks. Additionally, Mr. Kraws has been 5-Star Ranked for top biotechnology stock performance by Starmine.

Crystal Research Associates' unique and novel product, the Executive Informational Overview® (EIO®), is free of investment ratings, target prices, and forward-looking financial models. The EIO® presents a crystal clear, detailed report on a company (public or private) in a manner that is easily understood by the Wall Street financial community. The EIO® details a company's product/technology/service offerings, market size(s), key intellectual property, leadership, growth strategy, competition, risks, financial statements, key events, and other such fundamental information. Crystal Research Associates has offices in New York City, West Palm Beach, Montréal, and Toronto. Crystal Research Associates has been compensated by the Company in cash of forty-three thousand, five hundred dollars and four hundred thousand warrants for its services in creating this report, for updates, and for printing costs.

Forward-Looking Safe Harbor Statement

Statements in this news release regarding future financial and operating results, potential applications of the Company's technology, opportunities for the Company, and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including limited operating history, need for future capital, and economic conditions generally. Additional information on potential factors that could affect results and other risks and uncertainties are detailed from time to time in the Company's periodic reports, including forms filed with the SEC.

These statements, and other forward-looking statements, are not guarantees of future performance and involve risks and uncertainties. Crystal Research Associates assumes no obligation to update any of the forward-looking statements in this release.

Contact Information:

Contact:

Jeffrey J. Kraws
Karen B. Goldfarb
Crystal Research Associates, LLC
P: (609) 306-2274
F: (609) 395-9339